Whole-genome sequencing analysis to identify antimicrobial resistance regions and virulence factors in Mycobacterium tuberculosis isolates from the Amhara Region, Ethiopia

  10 May 2025

Tuberculosis, a major global health issue, is characterized by drug-resistant TB, particularly multidrug-resistant TB. In Ethiopia, a high TB-burden country, this study aimed to identify antimicrobial resistance regions and virulence factors in M. tuberculosis isolates using in silico whole-genome sequence analysis. The study identified the most prevalent TB-lineage in the Amhara region as L4 (58.53%), followed by L3 (34.15%), and L1 (4.88%). Drug resistance analysis revealed that 38 isolates (92.7%) were multidrug-resistant, with lineage 4 (59%) and its sub-lineage 4.2.2 showing the highest resistance. The study identified 67 virulence genes, with 63 occurring in all isolates. The high prevalence of MDR-TB and detection of resistance to both first- and second-line drugs highlight the urgent need for enhanced TB control measures in the Amhara region.

Further reading: Nature Scientific Reports
Author(s): Abebe Tesfaye Gessese et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!